Study participants were healthy individuals 70 years of age and older who had the ability to walk at least 70 feet unassisted. After being given 10 milligrams of methylphenidate, participants were monitored during separate and simultaneous cognitive and motor tests.
After study participants were administered the drug, they experienced decreases in the number and rate of step errors while walking and while walking with divided attention.
More Articles on Quality:
Hospital Compare Posts Risk-Adjusted PCI Readmission Rates for the First Time
Report: Healthcare is the Most Dangerous Workplace for Employees
CMS May Mimic Movie Critics With Star Ratings for Hospital Compare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
